Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy
The researchers hope that donor-derived cell-free DNA testing to monitor rejection can help relieve racial disparities in heart transplant outcomes.
Illumina, IDbyDNA Ink Partnership on NGS Technologies for Infectious Disease
The firms are developing clinical and RUO workflows that use NGS for pathogen identification and will comarket IDbyDNA's Explify data platform.
IDbyDNA Raises $20M in Series B Financing
The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.
Prescient Metabiomics, CoreBiome Developing Microbial Assay for Colon Cancer Screening
The companies are aiming to use microbial biomarkers to predict the development of precancerous adenomas and carcinomas.
Aperiomics Wins $229K NSF Award for Metagenomic Sequencing-Based Pathogen ID Tech
The funding will support the further development of Aperiomics' deep metagenomic shotgun sequencing-based test for identifying infectious disease pathogens.